Atrion Corporation (ATRI)
459.92
0.26 (0.06%)
At close: Aug 20, 2024, 8:00 PM
0.06% (1D)
| Bid | n/a |
| Market Cap | 809.44M |
| Revenue (ttm) | 181.6M |
| Net Income (ttm) | 12.56M |
| EPS (ttm) | 7.13 |
| PE Ratio (ttm) | 64.50490883590463 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 29,517 |
| Avg. Volume (20D) | 27,595 |
| Open | 459.75 |
| Previous Close | 459.66 |
| Day's Range | 459.75 - 460.26 |
| 52-Week Range | 274.98 - 503.24 |
| Beta | 0.69 |
About ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 18, 1980
Employees 712
Stock Exchange NASDAQ
Ticker Symbol ATRI
Website https://www.atrioncorp.com